They indicate that patients with iRBD and asymmetric DAT binding in the caudate nucleus had a higher risk of developing DLB, whereas those with more symmetric caudate nucleus DAT binding were at a higher risk of developing PD. Here, SLC6A3 is linked to Lewy body dementia.